Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-06-04

FDA Approved: METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic fixed-dose combination of metoprolol tartrate and hydrochlorothiazide, manufactured by Mylan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (metoprolol tartrate and hydrochlorothiazide)

Snippet

SUPPL AP for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE (METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE)